Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
 



 Ashmore Group plc

+0700 16 July 2009 

TRADING UPDATE AND ASSETS UNDER MANAGEMENT sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces the following trading update and Assets under Management ("AuM") statement in respect of the period ended 30 June 2009.

Assets under Management

Actual 

Estimated 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External Debt 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

The final quarter of the financial year ended 30 June 2009 saw AuM increase by US$1.4 billion (6%) to US$24.9 billion. This increase comprises investment performance of US$1.9 billion, arising in external debt and local currency, partially offset by net redemptions of US$0.5 billion, solely within the local 

currency theme.

During the financial year ended 30 June 2009, AuM decreased to US$24.9 billion from US$37.5 billion. Investment performance was US$5.1 billion adverseUS$7.1 billion adverse in the first half, and US$2.0 billion positive in the second half. Neredemptions in the period were US$7.4 billion, of which US$5.7 billion arose in the first half of the year across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levels have begun to increase within both public funds and segregated mandates, with net subscriptions achieved in May and June.  

The expansion of the average revenue margin experienced in the first half, principally because of the AuM mix, has been impacted by the timing and make up of external debt and local currency redemptions at the back end of the first half, and through the second half. This has resulted in the average revenue margin for the final quarter returning to the FY07/08 level of 103bps.  

The results for the full year ended 30 June 2009 are in-line with management expectations in the current operating environment. The loss for the year in respect of FX hedge contracts is £42.8 million (6 months to 31 December 2008: £54.2 million)of which £4.5 million (6 months to 31 December 2008: £12.7 million) relates to the mark-to-market of forward contracts to partially hedge FY09/10 management fees. These FY09/10 forward contracts have an aggregate notional value 

of US$120 million, marked at the year end rate of GBP1:1.6458USD. Any future gains or losses on these contracts will arise from deviations from this year end rate.

The Group will announce its results in respect of the financial year to 30 June 2009 on 

15 September 2009. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court133 Fleet Street London EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information, please contact:

Ashmore Group plc

Graeme Dell, Group Finance Director +44 (0)20 3077 6000

Penrose Financial  +44(0)20 7786 4888 

Gay Collins +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFVLDEIELIA
Date   Source Headline
16th Sep 20204:09 pmRNS2020 Annual Financial Report and Notice of AGM
11th Sep 20207:00 amRNSFinal Results
14th Jul 20207:00 amRNSTrading Statement
23rd Jun 20205:40 pmRNSDirector/PDMR Shareholding
19th Jun 20206:07 pmRNSDirector/PDMR Shareholding
19th Jun 20206:04 pmRNSHolding(s) in Company
27th Apr 20203:33 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:44 pmRNS2019 AGM voting result update statement
1st Apr 20209:51 amRNSDirector/PDMR Shareholding
16th Mar 20203:29 pmRNSHolding(s) in Company
13th Mar 20206:21 pmRNSDirector/PDMR Shareholding
7th Feb 20204:50 pmRNSDirector/PDMR Shareholding
7th Feb 20204:49 pmRNSHolding(s) in Company
6th Feb 20207:00 amRNSHalf-year Report
15th Jan 20207:00 amRNSTrading Statement
10th Dec 20199:16 amRNSDirector/PDMR Shareholding
9th Dec 20192:08 pmRNSDirector/PDMR Shareholding
11th Nov 201912:17 pmRNSDirector/PDMR Shareholding
21st Oct 201911:42 amRNSDirector Declaration
18th Oct 20193:32 pmRNSResult of AGM
16th Oct 20191:08 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSTrading Statement
30th Sep 20195:38 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSDirector/PDMR Shareholding
18th Sep 201912:04 pmRNSDirector/PDMR Shareholding
18th Sep 201912:01 pmRNSDirector/PDMR Shareholding
16th Sep 20192:07 pmRNS2019 Annual Report and Notice of AGM
6th Sep 20197:00 amRNSFinal Results
12th Jul 20197:00 amRNSTrading Statement
18th Apr 20195:08 pmRNSDirector/PDMR Shareholding
16th Apr 20197:00 amRNSTrading Statement
5th Apr 20198:57 amRNSDirector/PDMR Shareholding
3rd Apr 20194:37 pmRNSDirector/PDMR Shareholding
3rd Apr 20194:30 pmRNSHolding(s) in Company
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSTrading Statement
10th Dec 20182:14 pmRNSDirector/PDMR Shareholding
19th Oct 20185:08 pmRNSResult of AGM
12th Oct 20187:00 amRNSTrading Statement
1st Oct 20188:13 amRNSTotal Voting Rights
18th Sep 20186:04 pmRNSDirector/PDMR Shareholding
18th Sep 20186:00 pmRNSDirector/PDMR Shareholding
13th Sep 20184:16 pmRNSHolding(s) in Company
13th Sep 20184:11 pmRNSNotice of AGM
11th Sep 20185:19 pmRNSHolding(s) in Company
11th Sep 20185:04 pmRNSTreasury Shares
7th Sep 20187:00 amRNSFinal Results
6th Sep 20181:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.